Cyclotides: A patent review

Expert Opinion on Therapeutic Patents

Volumn 21, Issue 11, 2011, Pages 1657-1672

  Smith, Amanda B ^a   Daly, Norelle L ^a   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Circular proteins; Cyclic peptides; Cyclotides; Cystine knot; Drug design; Kalata B1

Indexed keywords

CYCLOTIDE; CYSTINE; KNOTTIN; POLYPEPTIDE; THROMBOPOIETIN; TRYPTASE INHIBITOR;

ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; MOLECULAR PROBE; NONHUMAN; PATENT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-HIV AGENTS; ANTI-INFECTIVE AGENTS; CYCLOTIDES; DRUG DESIGN; DRUG STABILITY; FEMALE; HUMANS; PATENTS AS TOPIC; PEPTIDES; UTERINE CONTRACTION;

EID: 80054912450     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2011.620606     Document Type: Article

References (118)

1. Craik DJ, Daly NL, Bond T, Waine C. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J Mol Biol 1999;294:1327-36 (Pubitemid 30008803)
2. Craik DJ, Daly NL, Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon 2001;39:43-60
3. Gran L, An oxytocic principle found in Oldenlandia affinis DC. Medd Nor Farm Selsk. 1970;12:173-80
4. Gran L. Isolation of oxytocic peptides from Oldenlandia affinis by solvent extraction of tetraphenylborate complexes and chromatography on sephadex LH-20. Lloydia 1973;36:207-8
5. Sletten K, Gran L. Some molecular properties of kalatapeptide B-1. A uterotonic polypeptide isolated from Oldenlandia affinis DC. Medd Nor Farm Selsk 1973;7-8:69-82
6. Saether O, Craik DJ, Campbell ID, et al. Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (Mosc) 1995;34:4147-58
7. Colgrave ML, Craik DJ. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry (Mosc) 2004;43:5965-75 (Pubitemid 38669464)
8. Gustafson KR, Sowder RCI, Henderson LE, et al. Circulins A and B: novel HIV-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. J Am Chem Soc 1994;116:9337-8
9. Witherup KM, Bogusky MJ, Anderson PS, et al. Cyclopsychotride A, A biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod 1994;57:1619-25
10. Goransson U, Luijendijk T, Johansson S, et al. Seven novel macrocyclic polypeptides from Viola arvensis. J Nat Prod 1999;62:283-6 (Pubitemid 29137907)
11. Wang CK, Kaas Q, Chiche L, Craik DJ. CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res 2008;36:D206-10 (Pubitemid 351149723)
12. Tam JP, Lu YA, Yang JL, Chiu KW. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc Natl Acad Sci USA 1999;96:8913-18 (Pubitemid 29374682)
13. Nguyen GK, Zhang S, Nguyen NT, et al. Discovery and characterization of novel cyclotides originated from chimeric precursors consisting of albumin-1 chain a and cyclotide domains in the Fabaceae family. J Biol Chem 2011;286:24275-87
14. Poth AG, Colgrave ML, Lyons RE, et al. Discovery of an unusual biosynthetic origin for circular proteins in legumes. Proc Natl Acad Sci USA 2011;108:10127-32
15. Poth AG, Colgrave ML, Philip R, et al. Discovery of cyclotides in the Fabaceae plant family provides new insights into the cyclization, evolution, and distribution of circular proteins. ACS Chem Biol 2011;6:345-55
16. Gruber CW, Elliott AG, Ireland DC, et al. Distribution and evolution of circular miniproteins in flowering plants. Plant Cell 2008;20:2471-83 (Pubitemid 352844612)
17. Craik DJ, Cemazar M, Wang CK, Daly NL. The cyclotide family of circular miniproteins: nature's combinatorial peptide template. Biopolymers 2006;84:250-66
18. Gran L. On the effect of a polypeptide isolated from "Kalata- Kalata" (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol 1973;33:400-8
19. Goransson U, Sjogren M, Svangard E, et al. Reversible antifouling effect of the cyclotide cycloviolacin O2 against barnacles. J Nat Prod 2004;67:1287-90 (Pubitemid 39145631)
20. Herrmann A, Burman R, Mylne J, et al. The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry 2008;69:939-52
21. Lindholm P, G'oransson U, Johansson S, et al. Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther 2002;1:365-9
22. Svangard E, Goransson U, Hocaoglu Z, et al. Cytotoxic cyclotides from Viola tricolor. J Nat Prod 2004;67:144-7 (Pubitemid 38282899)
23. Burman R, Svedlund E, Felth J, et al. Evaluation of toxicity and anti-tumour activity of cycloviolacin O2 in mice. Biopolymers Pept Sci 2010;94:626-34
24. Gerlach SL, Rathinakumar R, Chakravarty G, et al. Anticancer and chemosensitizing abilities of cycloviolacin O2 from Viola odorata and psyle cyclotides from Psychotria leptothyrsa. Biopolymers 2010;94:617-25
25. Craik DJ. Circling the enemy: cyclic proteins in plant defence. Trends Plant Sci 2009;14:328-35
26. Gruber CW, Cemazar M, Anderson MA, Craik DJ. Insecticidal plant cyclotides and related cystine knot toxins. Toxicon 2007;49:561-75 (Pubitemid 46341392)
27. Jennings C, West J, Waine C, et al. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc Natl Acad Sci USA 2001;98:10614-19 (Pubitemid 32878669)
28. Colgrave ML, Kotze AC, Ireland DC, et al. The anthelmintic activity of the cyclotides: natural variants with enhanced activity. ChemBioChem 2008;9:1939-45
29. Colgrave ML, Kotze AC, Kopp S, et al. Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms. Acta Trop 2009;109:163-6
30. Plan MR, Saska I, Cagauan AG, Craik DJ. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J Agric Food Chem 2008;56:5237-41 (Pubitemid 352039129)
31. Barbeta BL, Marshall AT, Gillon AD, et al. Plant cyclotides disrupt epithelial cells in the midgut of lepidopteran larvae. Proc Natl Acad Sci USA 2008;105:1221-5 (Pubitemid 351397034)
32. Adessi C, Soto C. Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 2002;9:963-78 (Pubitemid 34498572)
33. Tam JP, Lu Y-A. A biomimetic strategy in the synthesis and fragmentation of cyclic protein. Protein Sci 1998;7:1583-92 (Pubitemid 28331278)
34. Daly NL, Love S, Alewood PF, Craik DJ. Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Biochemistry (Mosc) 1999;38:10606-14
35. Craik DJ, Cemazar M, Daly NL. The chemistry and biology of cyclotides. Curr Opin Drug Discov Devel 2007;10:176-84 (Pubitemid 46438647)
36. Dawson PE, Muir TW, Clark-Lewis I, Kent SB. Synthesis of proteins by native chemical ligation. Science 1994;266:776-9 (Pubitemid 24359280)
37. Tam JP, Lu YA, Liu CF, Shao J. Peptide synthesis using unprotected peptides through orthogonal coupling methods. Proc Natl Acad Sci USA 1995;92:12485-9 (Pubitemid 26014094)
38. Daly NL, Clark RJ, Craik DJ. Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides. J Biol Chem 2003;278:6314-22 (Pubitemid 36800889)
39. Goransson U, Craik DJ. Disulfide mapping of the cyclotide kalata B1. Chemical proof of the cyclic cystine knot motif. J Biol Chem 2003;278:48188-96 (Pubitemid 37523272)
40. Gunasekera S, Daly NL, Anderson MA, Craik DJ. Chemical synthesis and biosynthesis of the cyclotide family of circular proteins. IUBMB Life 2006;58:515-24 (Pubitemid 44470237)
41. Craik DJ, Daly NL. Oxidative folding of the cystine knot motif in cyclotide proteins. Protein Pept Lett 2005;12:147-52 (Pubitemid 40335666)
42. Dutton JL, Renda RF, Waine C, et al. Conserved Structural and Sequence Elements Implicated in the Processing of Gene-encoded Circular Proteins. J Biol Chem 2004;279:46858-67 (Pubitemid 39518337)
43. Trabi M, Mylne JS, Sando L, Craik DJ. Circular proteins from Melicytus (Violaceae) refine the conserved protein and gene architecture of cyclotides. Org Biomol Chem 2009;7:2378-88
44. Zhang J, Liao B, Craik DJ, et al. Identification of two suites of cyclotide precursor genes from metallophyte Viola baoshanensis: cDNA sequence variation, alternative RNA splicing and potential cyclotide diversity. Gene 2009;431:23-32
45. Dornenburg H. Plant cell culture technology-harnessing a biological approach for competitive cyclotides production. Biotechnol Lett 2008;30:1311-21
46. Dornenburg H. Progress in kalata peptide production via plant cell bioprocessing. Biotechnol J 2009;4:632-45
47. Dornenburg H. Cyclotide synthesis and supply: from plant to bioprocess. Biopolymers 2010;94:602-10
48. Dornenburg H, Frickinger P, Seydel P. Plant cell-based processes for cyclotides production. J Biotechnol 2008;135:123-6
49. Seydel P, Dornenburg H. Establishment of in vitro plants, cell and tissue cultures from Oldenlandia affinis for the production of cyclic peptides. Plant Cell Tissue Org Cult 2006;85:247-55 (Pubitemid 43854269)
50. Seydel P, Gruber CW, Craik DJ, Dornenburg H. Formation of cyclotides and variations in cyclotide expression in Oldenlandia affinis suspension cultures. Appl Microbiol Biotechnol 2007;77:275-84 (Pubitemid 350029441)
51. Kimura RH, Tran A-T, Camarero JA. Biosynthesis of the cyclotide kalata B1 by using protein splicing. Angew Chem Int Ed 2006;118:987-90
52. Camarero JA, Kimura RH, Woo Y-H, et al. Biosynthesis of a fully functional cyclotide inside living bacterial cells. ChemBioChem 2007;8:1363-6 (Pubitemid 47300326)
53. Jagadish K, Camarero JA. Cyclotides, a promising molecular scaffold for peptide-based therapeutics. Biopolymers 2010;94:611-16
54. Marx UC, Korsinczky ML, Schirra HJ, et al. Enzymatic cyclization of a potent Bowman-Birk protease inhibitor, sunflower trypsin inhibitor-1, and solution structure of an acyclic precursor peptide. J Biol Chem 2003;278:21782-9 (Pubitemid 36792582)
55. Thongyoo P, Jaulent AM, Tate EW, Leatherbarrow RJ. Immobilized protease-assisted synthesis of engineered cysteine-knot microproteins. ChemBioChem 2007;8:1107-9 (Pubitemid 47194814)
56. Goransson U, Svangard E, Claeson P, Bohlin L. Novel strategies for isolation and characterization of cyclotides: the discovery of bioactive macrocyclic plant polypeptides in the Violaceae. Curr Protein Pept Sci 2004;5:317-29 (Pubitemid 39200162)
57. Ireland DC, Clark RJ, Daly NL, Craik DJ. Isolation, sequencing, and structure-activity relationships of cyclotides. J Nat Prod 2010;73:1610-22
58. Craik DJ, Conibear AC. The chemistry of cyclotides. J Org Chem 2011;76:4805-17
59. Craik DJ, Daly NL. NMR as a tool for elucidating the structures of circular and knotted proteins. Mol Biosyst 2007;3:257-65 (Pubitemid 46456310)
60. Chiche L, Heitz A, Gelly JC, et al. Squash inhibitors: from structural motifs to macrocyclic knottins. Curr Protein Pept Sci 2004;5:341-9 (Pubitemid 39200164)
61. Daly NL, Craik DJ. Bioactive cystine knot proteins. Curr Opin Chem Biol 2011;15:362-8
62. Henriques ST, Craik DJ. Cyclotides as templates in drug design. Drug Discov Today 2010;15:57-64
63. Garcia AE, Camarero JA. Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr Mol Pharmacol 2010;3:153-63
64. The University of Queensland. Cystine knot molecules. US7960340; 2000
65. The University of Queensland and Hexima Ltd. Novel nucleic acid molecules. WO0134829; 2000
66. Viogard AB. On-growth inhibiting compounds. WO0004055; 2000
67. Friedrich-Alexander-Universitat Erlangen-Nurnberg. Method for producing cyclic peptides from in vitro plant cell cultures. WO05108596; 2005
68. E.I. Du Pont De Nemours & Co. Nucleic acid molecules encoding cyclotide polypeptides and methods of use. US7232939; 2005
69. NascaCell Technologies. Use of microproteins as tryptase inhibitors. WO06032436; 2005
70. E.I. Du Pont De Nemours & Co. Insecticidal plant cyclotide with activity against homopteran insects. US7211658; 2005
71. Pioneer Hi Breed International, Inc. and E.I. Du Pont De Nemours & Co. Maize cyclo1 gene and promoter. WO06076189; 2006
72. NascaCell Technologies. Dimeric or multimeric microproteins. WO06094813; 2006
73. Elso Magyar Biodrog Kutato Es Fejleszto FKT. A pharmaceutical composition containing an extract of a medicinal herb belonging to the order of violales. WO2007026185; 2006
74. Amunix, Inc. Proteinaceous pharmaceuticals and uses thereof. WO2007038619; 2006
75. Singapore Polytechnic. Novel polypeptides for anti-viral treatment. WO2007149052; 2007
76. University of Southern California. Compositions and methods for the rapid biosynthesis and in vivo screening of biologically relevant peptides. WO2011005598; 2010
77. Craik DJ, Mylne JS, Daly NL. Cyclotides: macrocyclic peptides with applications in drug design and agriculture. Cell Mol Life Sci 2010;67:9-16
78. Clark RJ, Daly NL, Craik DJ. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem J 2006;394:85-93 (Pubitemid 43259658)
79. Gunasekera S, Foley FM, Clark RJ, et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem 2008;51:7697-704
80. Thongyoo P, Roque-Rosell N, Leatherbarrow RJ, Tate EW. Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org Biomol Chem 2008;6:1462-70 (Pubitemid 351469865)
81. Tan N-H, Zhou J. Plant cyclopeptides. Chem Rev 2006;106:840-95
82. Colgrave ML, Kotze AC, Huang YH, et al. Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry 2008;47:5581-9 (Pubitemid 351705169)
83. Jennings CV, Rosengren KJ, Daly NL, et al. Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Mobius strips exist in nature? Biochemistry 2005;44:851-60 (Pubitemid 40129645)
84. Tam JP, Lu Y-A, Yu Q. Thia zip reaction for synthesis of large cyclic peptides: mechanisms and applications. J Am Chem Soc 1999;121:4316-24
85. Gustafson KR, McKee TC, Bokesch HR. Anti-HIV cyclotides. Curr Protein Pept Sci 2004;5:331-40 (Pubitemid 39200163)
86. Gustafson KR, Walton LK, Sowder RCI, et al. New circulin macrocyclic polypeptides from Chassalia parvifolia. J Nat Prod 2000;63:176-8 (Pubitemid 30126913)
87. Daly NL, Clark RJ, Plan MR, Craik DJ. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem J 2006;393:619-26 (Pubitemid 43163802)
88. Daly NL, Craik DJ. Acyclic permutants of naturally occurring cyclic proteins. Characterization of cystine knot and beta -sheet formation in the macrocyclic polypeptide kalata B1. J Biol Chem 2000;275:19068-75 (Pubitemid 30422874)
89. Barry DG, Daly NL, Clark RJ, et al. Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity. Biochemistry 2003;42:6688-95 (Pubitemid 36666109)
90. Simonsen SM, Sando L, Rosengren KJ, et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J Biol Chem 2008;283:9805-13
91. Rice K, Spencer J. Inhibitors of human mast cell serine proteases and potential therapeutic applications. Expert Opin Ther Pat 1999;9:1537-55 (Pubitemid 29515558)
92. Kolmar H. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. Curr Opin Pharmacol 2009;9:608-14
93. Heitz A, Avrutina O, Le-Nguyen D, et al. Knottin cyclization: impact on structure and dynamics. BMC Struct Biol 2008;8:54
94. Werle M, Kafedjiiski K, Kolmar H, Bernkop-Schnurch A. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration. Int J Pharm 2007;332:72-9 (Pubitemid 46227767)
95. Werle M, Schmitz T, Huang HL, et al. The potential of cystine-knot microproteins as novel pharmacophoric scaffolds in oral peptide drug delivery. J Drug Target 2006;14:137-46 (Pubitemid 43878822)
96. Frank SJ. Receptor dimerization in GH and erythropoietin action-it takes two to tango, but how? Endocrinology 2002;143:2-10 (Pubitemid 34056396)
97. Grotzinger J. Molecular mechanisms of cytokine receptor activation. Biochim Biophys Acta 2002;1592:215-23 (Pubitemid 35284880)
98. Mellado M, Vila-Coro AJ, Martinez C, Rodriguez-Frade JM. Receptor dimerization: a key step in chemokine signaling. Cell Mol Biol 2001;47:575-82
99. Lok S, Foster DC. The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 1994;12:586-98 (Pubitemid 24361708)
100. Hunt P. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. Stem Cells 1995;13:579-87
101. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-31
102. Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009;60:193-206
103. Sancheti H, Camarero JA. "Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides. Adv Drug Deliv Rev 2009;61:908-17
104. Camarero JA, Muir TW. Biosynthesis of a head-to-tail cyclized protein with improved biological activity. J Am Chem Soc 1999;121:5597-8 (Pubitemid 29292991)
105. Camarero JA, Fushman D, Cowburn D, Muir TW. Peptide chemical ligation inside living cells: in vivo generation of a circular protein domain. Bioorg Med Chem 2001;9:2479-84 (Pubitemid 32834634)
106. Austin J, Wang W, Puttamadappa S, et al. Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. ChemBioChem 2009;10:2663-70
107. Austin J, Kimura RH, Woo YH, Camarero JA. In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1. Amino Acids 2010;38:1313-22
108. Luckett S, Garcia RS, Barker JJ, et al. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J Mol Biol 1999;290:525-33 (Pubitemid 29324836)
109. Korsinczky ML, Schirra HJ, Rosengren KJ, et al. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. J Mol Biol 2001;311:579-91 (Pubitemid 32816591)
110. Craik DJ. Seamless Proteins tie up their loose ends. Science 2006;311:1563-4
111. Cole AM, Wang W, Waring AJ, Lehrer RI. Retrocyclins: using past as prologue. Curr Protein Pept Sci 2004;5:373-81 (Pubitemid 39200167)
112. Maqueda M, Galvez A, Bueno MM, Sanchez-Barrena M. Peptide AS-48: prototype of a new class of cyclic bacteriocins. Curr Protein Pept Sci 2004;5:399-416 (Pubitemid 39200170)
113. Selsted ME. Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci 2004;5:365-71 (Pubitemid 39200166)
114. Trabi M, Craik DJ. Circular proteins - no end in sight. Trends Biochem Sci 2002;27:132-8 (Pubitemid 34219323)
115. Mylne JS, Colgrave ML, Daly NL, et al. Albumins and their processing machinery are hijacked for cyclic peptides in sunflower. Nat Chem Biol 2011;7:257-9
116. Koradi R, Billeter M, Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996;14:29-32
117. Gillon AD, Saska I, Jennings CV, et al. Biosynthesis of circular proteins in plants. Plant J 2008;53:505-15 (Pubitemid 351172020)
118. Saska I, Gillon AD, Hatsugai N, et al. An asparaginyl endopeptidase mediates in vivo protein backbone cyclisation. J Biol Chem 2007;282:29721-8 (Pubitemid 350043339)